---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-158318"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:20:49.198891+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Inhibikase shareholders approve equity plan increase; charter amendment fails

## Summary
- Milton H. Werner re-elected with 2,993,996 votes for, 100,914 withheld.
- Ratification of CohnReznick as auditor passed with 4,352,312 for, 21,268 against.
- Amendment to 2020 Equity Incentive Plan (increase of 2.5M shares) approved with 2,706,691 for.
- Proposal to eliminate 66 2/3% vote requirement for charter amendments failed (2,929,207 for, 120,362 against).
- All results include substantial broker non-votes on director election and equity plan.

## SEC filing metadata
- accession: 0001193125-24-158318
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312524158318/0001193125-24-158318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312524158318/d850029d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-158318
- JSON: https://secwatch.observer/filing/0001193125-24-158318.json
- Plain text: https://secwatch.observer/filing/0001193125-24-158318.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.